Company Filing History:
Years Active: 2011
Title: Stéphane Gadelle: Innovator in HIV Detection
Introduction
Stéphane Gadelle is a notable inventor based in Vauhallan, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of HIV infections. His innovative work has led to the development of a patented synthetic peptide that plays a crucial role in immunoassays.
Latest Patents
Stéphane Gadelle holds a patent for "Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies." This invention involves a synthetic peptide derived from the HIV-1 virus gp41, which has a specific sequence where X is either F or G. The patent outlines a method for preparing the synthetic peptide, as well as a composition and kit that includes the peptide. This synthetic peptide is utilized in immunoassays for the detection of infections caused by HIV-1 viruses. He has 1 patent to his name.
Career Highlights
Throughout his career, Stéphane has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Bio-Rad Pasteur and Bio-Rad Europe GmbH. His work in these organizations has contributed to advancements in diagnostic technologies.
Collaborations
Stéphane has collaborated with several professionals in his field, including Francois Yves Rieunier and François Rieunier. These collaborations have likely enhanced the development and application of his innovative ideas.
Conclusion
Stéphane Gadelle's contributions to HIV detection through his patented innovations highlight his role as a significant figure in medical diagnostics. His work continues to impact the field positively, aiding in the fight against HIV infections.